Viewing nowNewcosar Tablet 50 mg (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Dasan Pharmaceutical Co., Ltd.

MFDS item code 201508481 · Approved 2015.12.29 · Insurance code 678600610
Treatment of hypertension and kidney disease in patients with type 2 diabetes and hypertension
This medication lowers blood pressure in patients with hypertension, thereby reducing the risk of cardiovascular diseases. Furthermore, in hypertensive patients with type 2 diabetes, it helps to prevent or slow the progression of kidney disease. Therefore, it is effectively used for treating cardiovascular issues related to hypertension and kidney disease.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed when administered with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is this medicine once daily at 50 mg. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is necessary in elderly patients 75 years of age or younger. For elderly patients over 75 years of age, an initial dose of this medicine of 25 mg once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients receiving dialysis: An initial dose of this medicine of 25 mg once daily is recommended. 3) Patients with reduced intravascular effective circulating volume For patients who may have reduced intravascular effective circulating volume (e.g., patients receiving diuretics), an initial dose of this medicine of 25 mg once daily is recommended (see Precautions for Use). 4) Patients with hepatic impairment Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents 6 years of age and older who weigh at least 20 kg but less than 50 kg and can swallow tablets: The recommended dose is this medicine 25 mg once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents 6 years of age and older who weigh at least 50 kg: The usual recommended dose is this medicine 50 mg once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication can cause serious harm to the fetus, especially when taken during the second and third trimesters of pregnancy. Therefore, it should not be used by women who are pregnant or may become pregnant, and should be discontinued immediately if pregnancy is confirmed. This medication is contraindicated in patients with certain conditions. For example, patients allergic to this drug or its ingredients, those with severe liver dysfunction, patients with hereditary angioedema, and patients with primary hyperaldosteronism should not take this medication. Additionally, patients with diabetes or moderate to severe kidney dysfunction should not use this medication in combination with certain drugs. Elderly patients, patients with hyperkalemia, and those with mild to moderate liver dysfunction should be especially cautious when administering this medication and their condition should be closely monitored to prevent excessively low blood pressure. Generally, this medication is well-tolerated, but side effects such as muscle cramps, dizziness, upper respiratory infections, and nasal congestion may occur. Rarely, serious adverse reactions have been reported, including angioedema, liver function abnormalities, myalgia, hyperkalemia, and hypotension, requiring caution. During treatment with this medication, regular checks of blood pressure, kidney function, and electrolyte levels are necessary to ensure there are no abnormalities. Particularly, taking this medication in conjunction with potassium-sparing agents or potassium-containing salt substitutes may dangerously increase blood potassium levels, so this combination should be avoided. This medication may interact with other antihypertensive agents or certain analgesics, anticoagulants, etc., so if other medications are being taken, consult with a doctor or pharmacist. Breastfeeding women are advised not to take this medication; if it is absolutely necessary to take it, breastfeeding should be discontinued. Do not administer to children under 6 years of age or to children and adolescents with severe kidney dysfunction. In the event of an overdose, hypotension and tachycardia may occur, and immediate medical treatment is required as this medication cannot be removed by dialysis. During treatment, precautions should be taken as dizziness or drowsiness may occur while driving or operating machinery. Finally, keep this medication out of reach of children and do not transfer it to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. Also, it is important to keep the drug at a temperature between 1 and 30 degrees Celsius to maintain its effectiveness.
White oval film-coated tablet
30 tablets (bottle), 300 tablets (bottle)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Dasan Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.